Category: news 2018

We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on orphan drugs targeted at small niche markets. An orphan disease is a medical condition or disorder that affects less than 200,000 people in the US. The National Institutes of Health (NIH) has classified as many …

Why AI and blockchain are the solutions to developing orphan drug Read More »

The idea that a company’s success depends on how much it can leverage the skills of its employees’ bright minds is rapidly becoming an outdated concept. Companies that are equipped with technologies for collaborating with a vast pool of global talent will build a competitive advantage. Collaboration is essential for innovation and efficiency. Open source …

Blockchain can take pharma collaboration and innovation to new heights Read More »

Redundancies in any professional field mean dollars lost. But in healthcare, inefficiency can cost lives. That’s a reality that Gunjan Bhardwaj came to understand when his friend and mentor was diagnosed with cancer. When Bhardwaj accompanied him during grueling rounds of chemo, he was appalled at the lack of information evidence from which to draw …

New Blockchain Platform from Innoplexus Will Bring Us Better, Cheaper Drugs Read More »

In this special guest feature, Gunjan Bhardwaj, Founder and CEO of Innoplexus, discusses how data silos in pharma prevent the latest advancements in machine learning and data analytics from operating at their full potential, how AI and blockchain are transforming incentives in data sharing practices to promote greater transparency, and how companies can leverage open …

How Eliminating Data Silos Will Democratize Pharma R&D Read More »

Researchers tend to have a genuine scientific curiosity and desire to make the world better with their discoveries. They are often thrilled about laboratory experiments and preclinical studies, regardless of their outcomes. However, one big problem in scientific research is that there are only rewards for publishing “positive” outcomes. Most studies with questionable outcomes never …

Why blockchain is a dream come true for pharma researchers Read More »

The quest for innovation is a major driving force in pharma. From the discovery of therapeutic biologicals in the 1920s, such as Salvarsan and insulin, to the blockbuster drugs birthed in the 1990s, such as Lipitor and Humira, pharma has always been on a quest for novel, groundbreaking drug development. However, advancements in technology are constantly …

Four steps to building an innovation culture in pharma Read More »

Gunjan Bhardwaj is the Founder and CEO of the Innoplexus group. He was earlier with the Boston Consulting Group and before that the leader of the global business performance think-tank of Ernst & Young and a manager in the German practice with a solution focus on strategy and innovation. He has led projects in strategy, …

CEO and Founder Gunjan Bhardwaj, PhD On Driving Innovation and Ensuring Success Read More »

Don’t let the hype around blockchain fool you. Blockchain is only as useful as the solutions it provides. With all the excitement around blockchain as a means to simplify supply chains, streamline the financial sector, and cure the most persistent ills plaguing humanity, it’s tempting to forget that this talk has to give way to …

3 Reasons why Innoplexus is bringing Blockchain to Pharma Read More »